19-Jun-2026 21:11:10

AUROBINDO PHARMA : COMPLETES US FDA PRE-APPROVAL INSPECTION AT SUBSIDIARY

• The United States Food and Drug Administration (US FDA) conducted a PAI at Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company. • The inspection took place from June 10, 2026, to June 19, 2026. • The inspection concluded with 5 observations. • The company will respond to the observations within the stipulated time. • There is no impact on the Company's financials or operations due to the said action.

Aurobindo Pharma Ltd

← Back to feed